Skip to main content
UCSF Medical Center
UCSF Benioff Children's Hospitals
UCSF Logo
  • UCSF Logo
  • Specialties
      • Cancer

      • Cardiology & Heart Surgery

      • Dermatology

      • Endocrinology & Endocrine Surgery

      • Fetal Treatment

      • Gastroenterology

      • Infectious Disease

      • Neurology

      • Neurosurgery

      • Ophthalmology

      • Orthopedics

      • Otolaryngology – Head and Neck Surgery

      • Pediatrics

      • Pulmonology

      • Spine

      • Surgery

      • Urology

      • Women's Health

  • COVID-19
  • About Us
  • Refer a Patient
      • Refer a Patient

      • Refer a Pediatrics Patient

      • Transfer a Patient

      • Request a Consultation

      • UCSF MD Link

  • Clinical Trials

Hope Rugo, MD

Breast oncologist

Hope Rugo, MD

Dr. Hope Rugo is a hematologist and oncologist specializing in breast cancer treatment. Rugo joined the UCSF Carol Franc Buck Breast Care Center after a decade at UCSF Medical Center working in the area of malignant hematology and bone marrow transplantation for a variety of diseases, including breast cancer. Rugo, co-director of the Breast Oncology Clinical Trials Program, has a special interest in therapies for breast cancer and is the principal investigator for several clinical trials testing these treatments. She is a professor of medicine at UCSF and an investigator of SPORE (Specialized Program of Research Excellence in Breast Cancer) in the Bay Area.

View Full Profile

View Profile


Related Videos

Breast Cancer Treatment Strategies: Experts Break Down the Latest Video

Breast Cancer Treatment Strategies: Experts Break Down the Latest

Reporting from the renowned San Antonio Breast Cancer Symposium, UCSF specialists present new research findings relevant to the complicated decisions made daily in designing treatment plans for individual patients.

Cancer Immunotherapy: Promise and Pitfalls Video

Cancer Immunotherapy: Promise and Pitfalls

Oncologist David Oh speaks at the October 2017 Bay Area Breast Cancer Forum about key developments in immunotherapy like immune checkpoint inhibitors and T-cell therapies, plus its use in experimental approaches to breast cancer treatment.

Updates from the American Society of Clinical Oncology (ASCO) 2017 Video

Updates from the American Society of Clinical Oncology (ASCO) 2017

A June 2017 Bay Area Breast Cancer Forum discussion of updates from the ASCO annual meeting, covering PARP inhibitors, germline BRCA mutations, HER2-positive cancer, patient-reported outcomes, immunotherapy and more. Moderator: Dr. Hope Rugo

Additional Links

  • Refer a Patient

  • Find a Doctor

  • Medical Services

  • Clinical Trials

  • Continuing Medical Education

This Video Content is available for informational and educational purposes only. UCSF does not make any representation or warranties with respect to the accuracy, applicability, fitness, or completeness of the Video Content. The Regents of the University of California and its officers, agents or employees (UCSF) will not be liable for any damages of any kind arising from any use of the Video Content, which is provided as is, and without warranties. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.

©2002 - 2022 The Regents of The University of California